Sort
16,300 grants matching “fatty liver disease”
Dynamics of Altered Metabolic States using a Microfluidic Living Cell Platform
$239,417Abhinav Bhushan · Illinois Institute Of Technology · R00 · FY2016 · DK
Project 3: Environmental PPARγ Pathway Activators: Multifaceted Metabolic Disruptors Impacting Adipose and Bone Homeostatsis
$239,354Jennifer J Schlezinger · Boston University Medical Campus · P42 · FY2019 · ES
Alcohol metabolism in liver sinusoidal endothelial cells
$239,344Yasuko Iwakiri · Yale University · R21 · FY2015 · AA
Adiponectin Receptors and S1P Signaling in Beta Cell Survival and Proliferation
$239,262William L Holland · Ut Southwestern Medical Center · R00 · FY2016 · DK
Fatty Acid Binding Protein and Pathological Retinal Vascularization
$239,245Sule Cataltepe · Brigham And Women'S Hospital · R21 · FY2011 · EY
Link of beta cell proliferation and type 2 diabetes to epigenetic regulation.
$239,125Xianxin Hua · University Of Pennsylvania · R56 · FY2010 · DK
Airborne Particulate Matter, Endoplasmic Reticulum Stress and Hepatic Lipid Dysre
$239,086Kezhong Zhang · Wayne State University · R21 · FY2011 · ES
Mechanistic characterization of the anti-inflammatory function of thermogenic fat for the treatment of metabolic disorders
$239,040Evanna Louisa Mills · Dana-Farber Cancer Inst · R00 · FY2024 · DK
Effects of Maternal Obesity on Offspring Immune System
$238,965Edgar G. Engleman · Stanford University · R21 · FY2019 · HD
DMB (3,3-dimethyl-1-butanol) as a novel translational strategy for preventing and treating gut dysbiosis-associated arterial aging
$238,806Douglas R Seals · University Of Colorado · R21 · FY2019 · AG
Project 2: Lipin-1 and the development of ALD
$238,770Min You · Cleveland Clinic Lerner Com-Cwru · P50 · FY2020 · AA
Project 2: Lipin-1 and the development of ALD
$238,770Min You · Cleveland Clinic Lerner Com-Cwru · P50 · FY2019 · AA
Obesity and Hepatic Steatosis
$238,722Michael J Pagliassotti · Colorado State University · R01 · FY2008 · DK
Changes in Placental Thyriod Hormone Transport Associated with Maternal Obesity
$238,709Melissa Anne Suter · Baylor College Of Medicine · R00 · FY2018 · HD
The in vivo regulation of glucose homeostasis and lifespan by mTORC2
$238,520Dudley William Lamming · University Of Wisconsin-Madison · R00 · FY2015 · AG
Identification and Characterization of Novel Metabolic Regulators in Mouse and Human Liver
$238,518Ling Yang · Temple Univ Of The Commonwealth · K22 · FY2020 · HL
Obesity, Metabolic Syndrome and Asthma
$238,500Ian Paul Lewkowich · Cincinnati Childrens Hosp Med Ctr · R21 · FY2020 · AI
Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening
$238,500Mark T. Miedel · University Of Pittsburgh At Pittsburgh · UH3 · FY2025 · TR
Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening
$238,500Mark T. Miedel · University Of Pittsburgh At Pittsburgh · UH3 · FY2024 · TR
Palmitoleate Protects against Cholangiocyte Lipoapoptosis
$238,500Justin L. Mott · University Of Nebraska Lincoln · P20 · FY2014 · GM
Ultrasound Evaluation of Liver Steatosis
$238,500Shigao Chen · Mayo Clinic Rochester · R21 · FY2021 · DK
Hepatocyte Metabolic Stress Response to Alcoholic Fatty Liver
$238,445Takeshi Saito · University Of Southern California · R21 · FY2024 · AA
Multigenerational epigenetic programming induced by paternal obesity and prediabetes
$238,435David Ik Martin · Children'S Hospital & Res Ctr At Oakland · R01 · FY2020 · DK
Influence of Obesity on Endogenous Oxalate Synthesis
$238,396Ross P Holmes · University Of Alabama At Birmingham · P20 · FY2021 · DK
Ghrelin deficiency predisposes mice to aging-associated inflammation through compromised gut function and microbiota dysbiosis
$238,327Chia-Shan Wu · Texas A&M Agrilife Research · R21 · FY2019 · AG